Dobutamine Stress Echocardiography in LF/LG Aortic Stenosis and Wild-type Transthyretin Amyloid Cardiomyopathy

NARecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 2, 2024

Primary Completion Date

November 1, 2025

Study Completion Date

April 1, 2026

Conditions
Transthyretin Amyloid CardiomyopathyAortic Stenosis
Interventions
DIAGNOSTIC_TEST

Dobutamine stress echocardiography

Patients will be investigated with dobutamine stress echocardiography (increasing doses of dobutamine infusion and simulatneous echocardiogarphic evaluation) to assess aortic valve area and projected aortic valve area.

Trial Locations (1)

8200

RECRUITING

Department of Cardiology, Aarhus University Hospital, Aarhus

All Listed Sponsors
lead

Steen Hvitfeldt Poulsen

OTHER